Back to User profile » Dr Yanwei Li
Paper published by Dr Yanwei Li:
Original Research
Anlotinib as Third-Line or Later Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Real-World Efficacy and Safety Outcomes
Li Y, Li S, Li Y, Pan Z
Drug Design, Development and Therapy 2026, 20:584230
Published Date: 12 June 2026